Advance your academic career, collaborate globally, and expand your network— join now !

Prof. Jong-Ki Kim

Department of Biomedical Engineering, School of Medicine, Catholic University of...

Share Link

Share

Information

Dr Kim obtained BS in Astronomy/Physics from Seoul National University in 1982, and MS in Physics from KAIST/Korea in 1984. He was awarded a PhD in Biophysics from the State University of New York at Buffalo, New York, USA, 1992, followed by spending two years at Memorial-Sloan Kettering Cancer Center/Cornell Medical School, New York as a Fellow. Prof Jong-Ki Kim is based at Catholic University of Daegu, School of Medicine, Biomedical Engineering and Radiology, Daegu City, Korea, as chairman of biomedical engineering since 1995. In 2012-13, he was visiting professor at UC Berkeley, Bioengineering department. Current research subjects of his laboratory are nanomedicine including drug delivery using nanostructured materials, pioneering work on high-Z nanoradiator proton/heavy ion stimulation therapy in neurodegenerative diseases (AD, PD), atherothrombotic diseases and refractory cancer including malignant glioma. He discovered a noble molecular targeting electroceutical treatment for Alzheimer’s disease recently. Synchrotron X-ray diffraction transcranial brain imaging is also under developing by collaborating with international scientists. He is serving presently or served formerly as committee member in a number of professional scientific societes including Korean Photodynamic Association, Chief Executive committee for biomedical imaging user group in synchrotron radiation of Pohang Accelerator Laboratory (former), KOMAC (proton) and Raon (heavy ion).

Research Keywords & Expertise

Hydrogels
antioxidant activity
Chitosan
gallic acid
IPN

Fingerprints

5%
Hydrogels
5%
antioxidant activity
5%
Chitosan
5%
gallic acid
5%
IPN

Short Biography

Dr Kim obtained BS in Astronomy/Physics from Seoul National University in 1982, and MS in Physics from KAIST/Korea in 1984. He was awarded a PhD in Biophysics from the State University of New York at Buffalo, New York, USA, 1992, followed by spending two years at Memorial-Sloan Kettering Cancer Center/Cornell Medical School, New York as a Fellow. Prof Jong-Ki Kim is based at Catholic University of Daegu, School of Medicine, Biomedical Engineering and Radiology, Daegu City, Korea, as chairman of biomedical engineering since 1995. In 2012-13, he was visiting professor at UC Berkeley, Bioengineering department. Current research subjects of his laboratory are nanomedicine including drug delivery using nanostructured materials, pioneering work on high-Z nanoradiator proton/heavy ion stimulation therapy in neurodegenerative diseases (AD, PD), atherothrombotic diseases and refractory cancer including malignant glioma. He discovered a noble molecular targeting electroceutical treatment for Alzheimer’s disease recently. Synchrotron X-ray diffraction transcranial brain imaging is also under developing by collaborating with international scientists. He is serving presently or served formerly as committee member in a number of professional scientific societes including Korean Photodynamic Association, Chief Executive committee for biomedical imaging user group in synchrotron radiation of Pohang Accelerator Laboratory (former), KOMAC (proton) and Raon (heavy ion).